Firstsource Solutions Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 4, 2025, 4:13 pm

Competitors of Firstsource Solutions Ltd

All Competitor Stocks of Firstsource Solutions Ltd

Quarterly Result

Last Updated: August 1, 2025, 9:20 pm

Below is a detailed analysis of the quarterly data for Firstsource Solutions Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 2,218.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,161.00 Cr. (Mar 2025) to 2,218.00 Cr., marking an increase of 57.00 Cr..
• For Expenses, as of Jun 2025, the value is 1,871.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,829.00 Cr. (Mar 2025) to 1,871.00 Cr., marking an increase of 42.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 347.00 Cr.. The value appears strong and on an upward trend. It has increased from 333.00 Cr. (Mar 2025) to 347.00 Cr., marking an increase of 14.00 Cr..
• For OPM %, as of Jun 2025, the value is 16.00%. The value appears strong and on an upward trend. It has increased from 15.00% (Mar 2025) to 16.00%, marking an increase of 1.00%.
• For Other Income, as of Jun 2025, the value is 7.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Mar 2025) to 7.00 Cr., marking an increase of 5.00 Cr..
• For Interest, as of Jun 2025, the value is 43.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 43.00 Cr..
• For Depreciation, as of Jun 2025, the value is 97.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 91.00 Cr. (Mar 2025) to 97.00 Cr., marking an increase of 6.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 213.00 Cr.. The value appears strong and on an upward trend. It has increased from 202.00 Cr. (Mar 2025) to 213.00 Cr., marking an increase of 11.00 Cr..
• For Tax %, as of Jun 2025, the value is 21.00%. The value appears to be increasing, which may not be favorable. It has increased from 20.00% (Mar 2025) to 21.00%, marking an increase of 1.00%.
• For Net Profit, as of Jun 2025, the value is 169.00 Cr.. The value appears strong and on an upward trend. It has increased from 161.00 Cr. (Mar 2025) to 169.00 Cr., marking an increase of 8.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 2.39. The value appears strong and on an upward trend. It has increased from 2.27 (Mar 2025) to 2.39, marking an increase of 0.12.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 5:21 am

Growth

Last Updated: September 5, 2025, 4:15 am

Balance Sheet

Last Updated: July 25, 2025, 3:14 pm

Below is a detailed analysis of the balance sheet data for Firstsource Solutions Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 697.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 697.00 Cr..
• For Reserves, as of Mar 2025, the value is 3,401.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,003.00 Cr. (Mar 2024) to 3,401.00 Cr., marking an increase of 398.00 Cr..
• For Borrowings, as of Mar 2025, the value is 2,569.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 1,526.00 Cr. (Mar 2024) to 2,569.00 Cr., marking an increase of 1,043.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 1,091.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 702.00 Cr. (Mar 2024) to 1,091.00 Cr., marking an increase of 389.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 7,758.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5,929.00 Cr. (Mar 2024) to 7,758.00 Cr., marking an increase of 1,829.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 4,994.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,853.00 Cr. (Mar 2024) to 4,994.00 Cr., marking an increase of 1,141.00 Cr..
• For CWIP, as of Mar 2025, the value is 49.00 Cr.. The value appears strong and on an upward trend. It has increased from 17.00 Cr. (Mar 2024) to 49.00 Cr., marking an increase of 32.00 Cr..
• For Investments, as of Mar 2025, the value is 73.00 Cr.. The value appears strong and on an upward trend. It has increased from 42.00 Cr. (Mar 2024) to 73.00 Cr., marking an increase of 31.00 Cr..
• For Other Assets, as of Mar 2025, the value is 2,642.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,017.00 Cr. (Mar 2024) to 2,642.00 Cr., marking an increase of 625.00 Cr..
• For Total Assets, as of Mar 2025, the value is 7,758.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,929.00 Cr. (Mar 2024) to 7,758.00 Cr., marking an increase of 1,829.00 Cr..

Notably, the Reserves (3,401.00 Cr.) exceed the Borrowings (2,569.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Firstsource Solutions Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 8.63. This value is within the healthy range. It has increased from 7.52 (Mar 24) to 8.63, marking an increase of 1.11.
• For Diluted EPS (Rs.), as of Mar 25, the value is 8.42. This value is within the healthy range. It has increased from 7.34 (Mar 24) to 8.42, marking an increase of 1.08.
• For Cash EPS (Rs.), as of Mar 25, the value is 13.22. This value is within the healthy range. It has increased from 11.12 (Mar 24) to 13.22, marking an increase of 2.10.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 58.79. It has increased from 53.10 (Mar 24) to 58.79, marking an increase of 5.69.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 58.79. It has increased from 53.10 (Mar 24) to 58.79, marking an increase of 5.69.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 114.50. It has increased from 90.91 (Mar 24) to 114.50, marking an increase of 23.59.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 17.31. This value is within the healthy range. It has increased from 14.25 (Mar 24) to 17.31, marking an increase of 3.06.
• For PBIT / Share (Rs.), as of Mar 25, the value is 12.62. This value is within the healthy range. It has increased from 10.52 (Mar 24) to 12.62, marking an increase of 2.10.
• For PBT / Share (Rs.), as of Mar 25, the value is 10.63. This value is within the healthy range. It has increased from 9.03 (Mar 24) to 10.63, marking an increase of 1.60.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 8.53. This value is within the healthy range. It has increased from 7.38 (Mar 24) to 8.53, marking an increase of 1.15.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 8.53. This value is within the healthy range. It has increased from 7.38 (Mar 24) to 8.53, marking an increase of 1.15.
• For PBDIT Margin (%), as of Mar 25, the value is 15.12. This value is within the healthy range. It has decreased from 15.67 (Mar 24) to 15.12, marking a decrease of 0.55.
• For PBIT Margin (%), as of Mar 25, the value is 11.02. This value is within the healthy range. It has decreased from 11.56 (Mar 24) to 11.02, marking a decrease of 0.54.
• For PBT Margin (%), as of Mar 25, the value is 9.28. This value is below the healthy minimum of 10. It has decreased from 9.93 (Mar 24) to 9.28, marking a decrease of 0.65.
• For Net Profit Margin (%), as of Mar 25, the value is 7.44. This value is within the healthy range. It has decreased from 8.12 (Mar 24) to 7.44, marking a decrease of 0.68.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 7.44. This value is below the healthy minimum of 8. It has decreased from 8.12 (Mar 24) to 7.44, marking a decrease of 0.68.
• For Return on Networth / Equity (%), as of Mar 25, the value is 14.50. This value is below the healthy minimum of 15. It has increased from 13.91 (Mar 24) to 14.50, marking an increase of 0.59.
• For Return on Capital Employeed (%), as of Mar 25, the value is 16.01. This value is within the healthy range. It has decreased from 16.50 (Mar 24) to 16.01, marking a decrease of 0.49.
• For Return On Assets (%), as of Mar 25, the value is 7.50. This value is within the healthy range. It has decreased from 8.46 (Mar 24) to 7.50, marking a decrease of 0.96.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.08. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 24) to 0.08, marking an increase of 0.08.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.37. This value is within the healthy range. It has increased from 0.21 (Mar 24) to 0.37, marking an increase of 0.16.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.14. It has increased from 1.08 (Mar 24) to 1.14, marking an increase of 0.06.
• For Current Ratio (X), as of Mar 25, the value is 0.91. This value is below the healthy minimum of 1.5. It has decreased from 0.93 (Mar 24) to 0.91, marking a decrease of 0.02.
• For Quick Ratio (X), as of Mar 25, the value is 0.91. This value is below the healthy minimum of 1. It has decreased from 0.93 (Mar 24) to 0.91, marking a decrease of 0.02.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 46.40. This value is within the healthy range. It has decreased from 46.74 (Mar 24) to 46.40, marking a decrease of 0.34.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 29.93. This value is within the healthy range. It has decreased from 31.04 (Mar 24) to 29.93, marking a decrease of 1.11.
• For Earning Retention Ratio (%), as of Mar 25, the value is 53.60. This value is within the healthy range. It has increased from 53.26 (Mar 24) to 53.60, marking an increase of 0.34.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 70.07. This value exceeds the healthy maximum of 70. It has increased from 68.96 (Mar 24) to 70.07, marking an increase of 1.11.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 8.16. This value is within the healthy range. It has decreased from 9.61 (Mar 24) to 8.16, marking a decrease of 1.45.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.96. This value is within the healthy range. It has decreased from 5.98 (Mar 24) to 4.96, marking a decrease of 1.02.
• For Enterprise Value (Cr.), as of Mar 25, the value is 25,116.07. It has increased from 14,375.87 (Mar 24) to 25,116.07, marking an increase of 10,740.20.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.15. This value exceeds the healthy maximum of 3. It has increased from 2.27 (Mar 24) to 3.15, marking an increase of 0.88.
• For EV / EBITDA (X), as of Mar 25, the value is 20.81. This value exceeds the healthy maximum of 15. It has increased from 14.47 (Mar 24) to 20.81, marking an increase of 6.34.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.98. This value is within the healthy range. It has increased from 2.17 (Mar 24) to 2.98, marking an increase of 0.81.
• For Retention Ratios (%), as of Mar 25, the value is 53.59. This value is within the healthy range. It has increased from 53.25 (Mar 24) to 53.59, marking an increase of 0.34.
• For Price / BV (X), as of Mar 25, the value is 5.80. This value exceeds the healthy maximum of 3. It has increased from 3.72 (Mar 24) to 5.80, marking an increase of 2.08.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.98. This value is within the healthy range. It has increased from 2.17 (Mar 24) to 2.98, marking an increase of 0.81.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.02, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness